| 000 | 01556 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513034837.0 | ||
| 264 | 0 | _c19950914 | |
| 008 | 199509s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/0264-410x(94)00027-k _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGolde, W T | |
| 245 | 0 | 0 |
_aThe Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. _h[electronic resource] |
| 260 |
_bVaccine _cApr 1995 |
||
| 300 |
_a435-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibody Formation |
| 650 | 0 | 4 |
_aAntigens, Surface _xgenetics |
| 650 | 0 | 4 |
_aBacterial Outer Membrane Proteins _xgenetics |
| 650 | 0 | 4 | _aBacterial Vaccines |
| 650 | 0 | 4 |
_aBorrelia burgdorferi Group _ximmunology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipoproteins |
| 650 | 0 | 4 |
_aLyme Disease _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 | _aTicks |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xgenetics |
| 700 | 1 | _aBurkot, T R | |
| 700 | 1 | _aPiesman, J | |
| 700 | 1 | _aDolan, M C | |
| 700 | 1 | _aCapiau, C | |
| 700 | 1 | _aHauser, P | |
| 700 | 1 | _aDequesne, G | |
| 700 | 1 | _aLobet, Y | |
| 773 | 0 |
_tVaccine _gvol. 13 _gno. 5 _gp. 435-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0264-410x(94)00027-k _zAvailable from publisher's website |
| 999 |
_c7638440 _d7638440 |
||